Equity

Corporate Results

Aarti Drugs Ltd consolidated sales down 2.43% on year in Q2FY2026
(31-Jul-2026, 22:33 Hours IST)  
Aarti Drugs Ltd share price gained 2.64% to Rs 423.5. The Company's net profit softened by 9.28% to Rs 50.13 crore, while revenue from operations eased by 2.43% to Rs 702.78 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 23.86 lakh crore, gaining 5.88%. It has improved by 2.79% over last one week and rallied by 15.59% in last one month while the market capitalization of Aarti Drugs Ltd has marginally improved by 4.66% and 12.92% in the same period respectively. Profit before tax (PBT) of Aarti Drugs Ltd stood at Rs 69.24 crore in Q2 FY26, expanding by 35.47% year-on-year, and slipping 1.59% quarter-on-quarter. EBITDA came in at Rs 97 crore, surging by 32.02% YoY and rising 2.47% sequentially. Total expenses slightly declined by 3.03% to Rs 623.04 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 469.35 crore, posting a minor increase of 9.87% YoY, while employee benefits expense was at Rs 36.51 crore, surging 13.10% YoY. For the TTM ended FY26, revenue from operations declined slightly by 5.60% to Rs 2387.03 crore, while net profit slipped by 2.03% to Rs 168.1 crore, compared to previous TTM. EBITDA jumped by 31576% to Rs 270.7 crore, and PBT contracted 10.08% to Rs 211.77 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 244.58 crore in FY26, as against Rs 358.92 crore in FY25. Aarti Drugs Ltd crashed 21.03% in last one year, underperforming the benchmark BSE Sensex which has slipped by 4.36% during the same period.
Friday, July 31, 2026 12:00:00 AM
Adani Ports1699.50comprofit(2.12)%
      
Asian Paints2748.50comprofit(0.06)%
      
Axis Bank1229.55comprofit(0.06)%
      
Bajaj Finance1141.70comprofit(8.11)%
      
Bajaj Finserv2029.40comprofit(6.30)%
      
Bharat Electro..387.80comprofit(0.78)%
      
Bharti Airtel1971.15comprofit(0.79)%
      
Eternal302.35comprofit(-2.72)%
      
HCL Technologi..1346.50comprofit(-0.50)%
      
HDFC Bank747.90comprofit(-1.09)%
      
Hind. Unilever2100.80comprofit(-0.34)%
      
ICICI Bank1435.25comprofit(-0.09)%
      
Infosys1130.00comprofit(-2.26)%
      
Interglobe Avi..5170.75comprofit(-1.17)%
      
ITC280.95comprofit(-1.51)%
      
Kotak Mah. Ban..390.20comprofit(0.32)%
      
Larsen & Toubr..3938.60comprofit(0.00)%
      
M & M3396.35comprofit(3.58)%
      
Maruti Suzuki14239.40comprofit(0.36)%
      
NTPC347.15comprofit(0.77)%
      
Power Grid Cor..284.30comprofit(-0.49)%
      
Reliance Indus..1307.30comprofit(1.00)%
      
SBI1026.80comprofit(0.06)%
      
Sun Pharma.Ind..1989.35comprofit(-0.57)%
      
Tata Steel189.80comprofit(1.52)%
      
TCS2365.60comprofit(-2.73)%
      
Tech Mahindra1651.60comprofit(-1.03)%
      
Titan Company4875.30comprofit(0.56)%
      
Trent3004.60comprofit(0.18)%
      
UltraTech Cem.11904.70comprofit(0.48)%
      

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)